Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure
June 01, 2012 08:58 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Jun 1, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2012 Financial Results
May 14, 2012 19:48 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - May 14, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS)
$2.2 million in revenue for second quarter 2012; $4.4...
BARDA Exercises $9.1 Million in Contract Options With Aeolus
April 16, 2012 08:41 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Apr 16, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
BARDA Delivers Notice of Intent to Exercise Additional Contract Options With Aeolus Worth $9.1 Million
April 09, 2012 04:00 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Apr 9, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS)
BARDA notice of intent to exercise options valued at...
Aeolus Pharmaceuticals Announces Date and Time for Barda Contract and Corporate Update Conference Call
April 05, 2012 15:39 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Apr 5, 2012) - Aeolus Pharmaceuticals (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
PositiveID Corporation Awarded U.S. Patent No. 8,133,451 for First-of-Its-Kind Detection System for Molecular Biological Diagnostics
March 20, 2012 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., March 20, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as...
PositiveID Corporation's M-BAND Well Positioned for $3 Billion BioWatch Contract
March 13, 2012 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., March 13, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of molecular diagnostic systems for bio-threat detection, announced today that...
Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference
March 13, 2012 06:00 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Mar 13, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
Aeolus Announces No-Cost Extension and Modification of Barda Contract Fully Valued at $118 Million to Develop Treatment for Lung Acute Radiation Syndrome
February 15, 2012 10:35 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Feb 15, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS)
Restructure driven by additional items added to base...
Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2012 Financial Results
February 13, 2012 17:40 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Feb 13, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS)
$2.2 million in revenue
Meeting to request...